Revenue

QuinStreet's major acquisition of HomeBuddy aims to reshape the digital home services market by combining scale with exclusive, high-intent contractor leads.

As the HYROX fitness race explodes in popularity, MOVATI Athletic has certified all five Ottawa clubs, positioning the city as a hub for hybrid athletes.

With a key presentation looming, Star Therapeutics aims to showcase its universal hemostatic therapy, VGA039, for von Willebrand disease.

Dnsys scores three CES 2026 Innovation Awards for its Z1 exoskeleton, merging advanced human augmentation with gaming culture for the consumer market.

Routeware appoints proven tech leaders Jeremy Collins and Ray Greer to drive its next growth phase, focusing on platform modernization and market leadership.

Vanadium giant Largo Inc. inks a binding term sheet to sell a decade's worth of byproduct, a move that could boost its finances and green credentials.

As the private equity market rebounds, Evercore hires a seasoned banker to strengthen its financial sponsors group, signaling a major strategic play.

A new report shows nearly half of homeowners may move due to climate risk, as soaring insurance and mortgage costs redefine the American dream.

With blockbuster sales from VYJUVEK, Krystal Biotech heads to J.P. Morgan with investors eager for news on its global growth and ambitious pipeline.

A tiny implant stimulating the vagus nerve offers new hope for severe RA. A landmark study now validates this bioelectric therapy for patients out of options.

Off The Hook's new luxury division leverages AI and an integrated model to secure ~$100M in listings and close 22 deals in its explosive first quarter.

A new integration brings Ceres AI's insights directly into the John Deere Operations Center, tackling data fragmentation for growers and insurers alike.

EZCORP acquires a controlling stake in Founders One, adding 105 pawn stores and signaling a major consolidation in the alternative finance sector.

New AMA codes for PolarityBio's SkinTE signal a strategic step toward commercialization, aiming to ease clinical adoption for chronic wound care.

Weight Watchers now offers the new Wegovy pill, a needle-free option, betting its future on combining powerful GLP-1 drugs with its classic support.

A new therapy claims to reverse cellular aging to cure disease, but its patient-funded trial model sparks a debate on equity and medical ethics.

A new tech alliance aims to replace manual cementing with standardized, automated systems for safer, more reliable wells across the entire asset lifecycle.

Vantage Corp finalizes its PJ Marine Singapore acquisition, a strategic move into China's lucrative market despite recent financial headwinds.

Amid a capacity crisis, a new model blending AI with human oversight gains traction, promising efficiency without sacrificing the crucial element of patient care.

China's ETF market had a record 2025, fueled by AI breakthroughs and state support. A look at the boom, the leaders, and the risks ahead.